Your browser doesn't support javascript.
loading
Association Between Human Papillomavirus Infection Among Pregnant Women and Preterm Birth.
Niyibizi, Joseph; Mayrand, Marie-Hélène; Audibert, François; Monnier, Patricia; Brassard, Paul; Laporte, Louise; Lacaille, Julie; Zahreddine, Monica; Bédard, Marie-Josée; Girard, Isabelle; Francoeur, Diane; Carceller, Ana Maria; Lacroix, Jacques; Fraser, William; Coutlée, François; Trottier, Helen.
Afiliación
  • Niyibizi J; Department of Social and Preventive Medicine, Université de Montréal, Montreal, Québec, Canada.
  • Mayrand MH; Centre de Recherche du Centre Hospitalier Universitaire Sainte-Justine, Université de Montréal, Montreal, Québec, Canada.
  • Audibert F; Department of Social and Preventive Medicine, Université de Montréal, Montreal, Québec, Canada.
  • Monnier P; Department of Obstetrics and Gynecology, Université de Montréal, Montreal, Québec, Canada.
  • Brassard P; Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, Québec, Canada.
  • Laporte L; Department of Obstetrics and Gynecology, Université de Montréal, Montreal, Québec, Canada.
  • Lacaille J; Department of Obstetrics and Gynecology, Centre Hospitalier Universitaire Sainte-Justine, Université de Montréal, Montreal, Québec, Canada.
  • Zahreddine M; Department of Obstetrics and Gynecology, McGill University, Montreal, Québec, Canada.
  • Bédard MJ; Research Institute of the McGill University Health Center, Montreal, Québec, Canada.
  • Girard I; Research Institute of the McGill University Health Center, Montreal, Québec, Canada.
  • Francoeur D; Division of Clinical Epidemiology, McGill University, Montreal, Québec, Canada.
  • Carceller AM; Centre de Recherche du Centre Hospitalier Universitaire Sainte-Justine, Université de Montréal, Montreal, Québec, Canada.
  • Lacroix J; Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, Québec, Canada.
  • Fraser W; Centre de Recherche du Centre Hospitalier Universitaire Sainte-Justine, Université de Montréal, Montreal, Québec, Canada.
  • Coutlée F; Department of Obstetrics and Gynecology, Université de Montréal, Montreal, Québec, Canada.
  • Trottier H; Department of Obstetrics and Gynecology, St-Mary's Hospital Center, Montreal, Québec, Canada.
JAMA Netw Open ; 4(9): e2125308, 2021 09 01.
Article en En | MEDLINE | ID: mdl-34524433
ABSTRACT
Importance Preterm birth remains a leading cause of perinatal mortality and lifelong morbidity worldwide. The cause of most preterm births is unknown, although several infectious processes have been implicated.

Objective:

To assess whether human papillomavirus (HPV) infection, a frequent infection among women of childbearing age, is associated with preterm birth. Design, Setting, and

Participants:

The prospective HERITAGE cohort study was conducted at 3 academic hospitals in Montreal, Québec, Canada, among 899 pregnant women recruited between November 8, 2010, and October 16, 2016. Follow-up was completed on June 15, 2017. Statistical analysis was conducted from February 6, 2020, to January 21, 2021. Exposures Vaginal HPV DNA detection in the first and third trimesters of pregnancy and placental HPV infection. Main Outcomes and

Measures:

The main outcome was preterm birth (defined as a live birth or stillbirth between 20 weeks and 0 days and 36 weeks and 6 days of gestation). The association between HPV DNA detection and preterm birth was measured using logistic regression. Odds ratios (ORs) and 95% CIs were adjusted by inverse probability of treatment weights of the propensity score.

Results:

The study included 899 women (mean [SD] age, 31.3 [4.6] years [range, 19-47 years]) with singleton pregnancies. A total of 378 women (42.0%) had HPV DNA detected in vaginal samples collected during the first trimester, and it was detected in 91 of 819 placentas (11.1%) at delivery. Fifty-five participants experienced preterm birth (38 spontaneous and 17 medically indicated). Persistent vaginal HPV-16/18 detection was significantly associated with all preterm births (adjusted OR [aOR], 3.72; 95% CI, 1.47-9.39) and spontaneous preterm births (aOR, 3.32; 95% CI, 1.13-9.80), as was placental HPV infection (all preterm births aOR, 2.53; 95% CI, 1.06-6.03; spontaneous preterm births aOR, 2.92; 95% CI, 1.09-7.81). Results were similar when restricting the analysis to participants without a history of cervical intraepithelial neoplasia treatment. Conclusions and Relevance The study's results suggest that persistent HPV-16/18 infection is associated with an increased risk of preterm birth, independent of cervical treatment. Future studies should investigate the association of HPV vaccination and vaccination programs with the risk of preterm birth.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Complicaciones Infecciosas del Embarazo / Enfermedades Vaginales / Infecciones por Papillomavirus / Nacimiento Prematuro Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Female / Humans / Newborn / Pregnancy País/Región como asunto: America do norte Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Complicaciones Infecciosas del Embarazo / Enfermedades Vaginales / Infecciones por Papillomavirus / Nacimiento Prematuro Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Female / Humans / Newborn / Pregnancy País/Región como asunto: America do norte Idioma: En Año: 2021 Tipo del documento: Article